Abstract:Abstract Background Treatment of coronary bifurcation lesions remains challenging; a simple strategy has been preferred as of late, but the disadvantage is ostium stenosis or even occlusion of the side branch (SB). Only a few single-center studies investigating the combination of a drug-eluting stent in the main branch followed by a drug-eluting balloon in the SB have been reported. This prospective, multicenter, randomized study aimed to investigate the safety and efficacy of a paclitaxel-eluting balloon (PEB) compared with regular balloon angioplasty (BA) in the treatment of non-left main coronary artery bifurcation lesions. Methods Between December 2014 and November 2015, a total of 222 consecutive patients with bifurcation lesions were enrolled in this study at ten Chinese centers. Patients were randomly allocated at a 1:1 ratio to a PEB group (n = 113) and a BA group (n = 109). The primary efficacy endpoint was angiographic target lesion stenosis at 9 months. Secondary efficacy and safety endpoints included target lesion revascularization, target vessel revascularization, target lesion failure, major adverse cardiac and cerebral events (MACCEs), all-cause death, cardiac death, non-fatal myocardial infarction, and thrombosis in target lesions. The main analyses performed in this clinical trial included case shedding analysis, base-value equilibrium analysis, effectiveness analysis, and safety analysis. SAS version 9.4 was used for the statistical analyses. Results At the 9-month angiographic follow-up, the difference in the primary efficacy endpoint of target lesion stenosis between the PEB (28.7% ± 18.7%) and BA groups (40.0% ± 19.0%) was –11.3% (95% confidence interval: –16.3% to –6.3%, P superiority <0.0001) in the intention-to-treat analysis, and similar results were recorded in the per-protocol analysis, demonstrating the superiority of PEB to BA. Late lumen loss was significantly lower in the PEB group than in the BA group (–0.06 ± 0.32 vs. 0.18 ± 0.34 mm, P < 0.0001). For intention-to-treat, there were no significant differences between PEB and BA in the 9-month percentages of MACCEs (0.9% vs. 3.7%, P = 0.16) or non-fatal myocardial infarctions (0 vs. 0.9%, P = 0.49). There were no clinical events of target lesion revascularization, target vessel revascularization, target lesion failure, all-cause death, cardiac death or target lesion thrombosis in either group. Conclusions In de novo non-left main coronary artery bifurcations treated with provisional T stenting, SB dilation with the PEB group demonstrated better angiographic results than treatment with regular BA at the 9-month follow-up in terms of reduced target lesion stenosis. Trial registration ClinicalTrials.gov, NCT02325817; https://clinicaltrials.gov

Comparative Study for Clinical Effect on Coronary Artery Bifurcation Lesions between T Stenting and Small Protrusion Technique and Modified Mini-Crush Stenting Technique

Clinical Observation of Simple Drug Coated Balloon Angioplasty in the Treatment of Coronary Bifurcation Lesions

Study on DK crush versus provisional stenting technique for treatment of coronary artery bifurcation lesions

Treatment Of Bifurcation Lesions With Two Stents: One Year Angiographic And Clinical Follow Up Of Crush Versus T Stenting

BIFURCATION STENTING FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISTAL LESIONS IN THE DRUG ELUTING STENT ERA: ONE-YEAR CLINICAL FOLLOW-UP RESULTS FROM A SINGLE CENTRE

Stenting techniques for coronary bifurcation disease: a systematic review and network meta-analysis demonstrates superiority of double-kissing crush in complex lesions

Study on the effect of application of jailed balloon for interventional treatment of bifurcation lesions in coronary artery and the incidence of opening and closing of vascular branches

Clinical Outcomes Following Coronary Bifurcation PCI Techniques: A Systematic Review and Network Meta-Analysis Comprising 5,711 Patients.

Five-year outcomes of double kissing mini-culotte stenting vs. mini-culotte stenting using drug-eluting stents for the treatment of true coronary bifurcation lesions

Randomized Comparison of FFR-Guided and Angiography-Guided Provisional Stenting of True Coronary Bifurcation Lesions: the DKCRUSH-VI Trial (double Kissing Crush Versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions VI).

Effect of different stent implantation time for percutaneous coronary intervention on efficacy and prognosis of acute ST-segment elevation myocardial infarction

[Comparison of Outcomes of Two Minimally Invasive Approaches for Multi-Vessel Coronary Revascularization].

Clinical Outcomes of Various Two Stent Bifurcation Techniques in Treating Coronary Bifurcation Lesions at Pakistan Institute of Medical Sciences (PIMS), Islamabad

Internal structure of a Landau quasiparticle wave packet.

Five-Year Clinical Follow-Up of Unprotected Left Main Bifurcation Lesion Stenting: One-Stent Versus Two-Stent Techniques Versus Double-Kissing Crush Technique

Clinical Outcomes after Recanalization of a Chronic Total Occluded Vessel with Bifurcation Lesions: Results from Single-Center, Prospective, Chronic Total Occlusion Registry Study.

Intravascular Ultrasound-Guided Systematic Two-Stent Techniques for Coronary Bifurcation Lesions and Reduced Late Stent Thrombosis

Crush Stenting In Treating Coronary Bifurcate Lesions: Paclitaxel Eluting Stents Versus Sirolimus Eluting Stents

Effect of Intracoronary Stenting for Bifurcational Lesions on the Side Branches

A Drug-Eluting Balloon for the Treatment of Coronary Bifurcation Lesions in the Side Branch: a Prospective Multicenter Randomized (BEYOND) Clinical Trial in China

Efficacy of emergency percutaneous coronary intervention for acute myocardial infarction patients with bifurcation lesion